Similar patterns of reduced expression were observed in B-ALL subtypes and CLL, suggesting widespread suppression of TSPAN32 across lymphoid malignancies (Figure 1). This evidence concerns the gene TSPAN32 and B-cell chronic lymphocytic leukemia.